# Cognitive-behavioral Therapy for Mental Disorder in COVID-19 Survivors

> **NCT05815693** · NA · UNKNOWN · sponsor: **Azienda Socio Sanitaria Territoriale di Lecco** · enrollment: 140 (estimated)

## Conditions studied

- Post Acute COVID-19 Syndrome

## Interventions

- **BEHAVIORAL:** mindfulness-based stress reduction (MBSR) and cognitive behavioral therapy (CBT)

## Key facts

- **NCT ID:** NCT05815693
- **Lead sponsor:** Azienda Socio Sanitaria Territoriale di Lecco
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-04-13
- **Primary completion:** 2023-11-30
- **Final completion:** 2023-11-30
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2023-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05815693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05815693, "Cognitive-behavioral Therapy for Mental Disorder in COVID-19 Survivors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05815693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*